@article{30bbc6d8d8c64489845e0aa6ef6d5cf1,
title = "Multiple sclerosis in 2021: progress against progression",
author = "Beck, {Erin S.} and Reich, {Daniel S.}",
note = "Funding Information: ESB is supported by a National Multiple Sclerosis Society Career Transition Award. ESB has a patent pending (US Patent application 62/838,578) on MRI acquisition and analysis methods relevant to multiple sclerosis. DSR is supported by the Intramural Research Program of NINDS (NIH) and the Adelson Medical Research Foundation. DSR reports non-financial support from PureTech Health, personal fees from Bounds Law Group, grants from Vertex, non-financial support from Biogen, grants from Sanofi-Genzyme, and grants from Abata Therapeutics, outside the submitted work; and has patents issued (US Patent 9,607,392 and US Patent 9,888,876) and pending (US Patent application 16/254,710 and US Patent application 62/838,578) covering MRI acquisition and analysis methods relevant to multiple sclerosis.",
year = "2022",
month = jan,
doi = "10.1016/S1474-4422(21)00417-8",
language = "English",
volume = "21",
pages = "12--13",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Elsevier Ltd.",
number = "1",
}